Clinical Trial Details
— Status: Enrolling by invitation
Administrative data
NCT number |
NCT06306976 |
Other study ID # |
2066031 |
Secondary ID |
|
Status |
Enrolling by invitation |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 2024 |
Est. completion date |
August 2025 |
Study information
Verified date |
March 2024 |
Source |
Prisma Health-Upstate |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Prospective cohort study of patients with midline ventral incisional hernia with a range of
hernia morphology who plan to undergo open retromuscular VHR.
Study groups: Study groups are selected across a range of morphology and based on factors
known or suspected to affect the ability to achieve fascial closure.
Control groups: The study plans to enlist 5 volunteers with no incisional hernia or prior
laparotomy to establish internal baseline SWE values and interrater reliability. The study
will also plan to recruit 5 patients undergoing primary laparotomy in order to correlate SWE
findings with closure tension.
Description:
Shear wave elastography can be used to predict abdominal wall compliance pre-operatively and
can therefore be used as a tool to improve surgical outcomes.
Specific Aim 1:
Determine the elasticity of abdominal wall muscles (rectus abdominis, external oblique,
internal oblique, and transversus abdominis) through shear wave elastography in patients with
midline incisional hernias of varying complexity and morphology.
Specific Aim 2:
Correlate shear wave elastography measurements of the abdominal wall with the extent of MFR
required to achieve fascial closure.
Specific Aim 3:
Correlate SWE-determined elasticity of abdominal wall to intraoperative assessment of tension
required to achieve fascial closure.
Imaging:
Ultrasound procedure will involve the following steps:
1. For control group 1 and group 2 patients, Images will be taken at two points along the
bilateral RA; at the level of the umbilicus and midway between the umbilicus and xiphoid
process. Bilateral external oblique (EO), internal oblique (IO), and transversus
abdominis (TA) images will be performed at the level of the anterior axillary line
midway between the costal margin and iliac crest.
2. For study patients, a single point of the bilateral RA will be selected at the
longitudinal mid-point of the hernia defect. Bilateral EO, IO, and TA images will be
performed at the level of the anterior axillary line midway between the costal margin
and iliac crest.
3. Gray-scale imaging will first determine thickness and texture of each muscle layer.
Texture analysis includes use of overlying subcutaneous fat as the internal control
value.
4. SWE will be performed at each location with three successive maneuvers:
1. With minimal external pressure applied by the ultrasound probe.
2. Manual compression applied with the ultrasound probe (maximum pressure allowable
without causing patient discomfort).
3. During Valsalva.
Hernia repair:
All study patients will have an open retromuscular repair with/without additional lateral MFR
(TAR or EOR at the discretion of the operating surgeon). All repairs beginning with
retrorectus dissection to the level of the linea semilunaris. When needed, additional MFR
progresses as follows:
1. For posterior myofascial release (TAR):
1. Incision of the posterior lamella of the internal oblique (PLIO) just medial the
intercostal neurovascular bundles and linea semilunaris
2. Division of the transversus abdominis muscle / aponeurosisis
3. Lateral dissection to progressively separate the peritoneum from the transversus
abdominis.
2. For anterior release (EOR):
1. Subcutaneous flaps developed to the anterior or midaxillary line bilaterally.
2. Division of the external oblique fascial and muscle 1cm or greater from the lateral
border of the rectus sheath / linea semilunaris.
3. Lateral dissection to progressively separate the external and internal oblique
muscles.
All patients will have permanent mesh reinforcement of the abdominal wall (large-pore,
midweight polypropylene). Fascia will be closed over the mesh with 0 or 2-0 polydioxanone
slowly absorbable suture using a small-bite technique and a 4:1 suture length:wound length
ratio.
Control group 1 patients will have no incisional hernia or prior laparotomy.
Control group 2 patients will have no hernia and will be undergoing elective midline
laparotomy.
Tensiometry For all study patients, an analog spring-tensiometer will be used to assess
intraoperative tension required to bring the fascia to the midline for closure. The
tensiometer is attached to a clamp attached to the fascia at the midpoint of the hernia
defect. Tension required for medialization to the midline will be performed after
adhesiolysis (baseline), retrorectus dissetion, incision of the PLIO (if performed), and
after completion of TAR or EOR (if performed).
Control group 2 patients will be undergoing first time laparotomy and will have tensiometry
performed. As control group 1 is not having surgery, no tensiometry will be done.